Fairvalue-Calculator Fairvalue-Calculator
EN DE

Sinil Pharmaceutical Co (012790) Fair Value & Analysis

Healthcare · KR · Market cap 63.6B KRW

Price5,000 KRW
Fair Value8,363 KRW
Upside+67.3%
Quality95/100
Evidence: High Range 6,272 KRW – 10,454 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Sinil Pharmaceutical Co (012790) currently trades at 5,000 KRW, while our model-based Fair Value estimate is 8,363 KRW — implying the stock looks roughly 67.3% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Sinil Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers pharmaceutical products for various indications, such as pain reliever, anti-inflammatory, hyperlipidemia, skin disease, and folic acid deficiency; and general/specialty drugs, veterinary drugs, and OEM products for various diseases. The company also provides cosmetics, including skin care products, etc.; health functional products comprising vitamin supplements; and quasi-drugs for yellow dust, bacteria blocking, etc. In addition, it is involved in the real estate rental services. The company was founded in 1971 and is headquartered in Chungju-si, South Korea.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +3193% Jiangsu Hengrui Pharmaceuticals Co (600276) -37% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -1% Hansoh Pharmaceutical Group (3692) -37% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is Sinil Pharmaceutical Co (012790) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 8,363 KRW versus a price of 5,000 KRW — about +67% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 012790?
Our 21-model fair value for Sinil Pharmaceutical Co is 8,363 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 5,000 KRW.
What is the quality score of 012790?
Sinil Pharmaceutical Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.